Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M68,920Revenue $M21,848Net Margin (%)8.5Z-Score3.8
Enterprise Value $M72,449EPS $1.6Operating Margin %13.3F-Score6
P/E(ttm))35.9Cash Flow Per Share $6.7Pre-tax Margin (%)12.8Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %-1.2Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-22.9Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %81.7ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)8.3Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M1,506ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTKen Fisher 2014-09-30 Reduce$41.05 - $43.69
($42.33)
$ 45.778%Reduce -37.53%11,261
ABTMason Hawkins 2014-09-30 Reduce-0.26%$41.05 - $43.69
($42.33)
$ 45.778%Reduce -8.8%12,483,566
ABTMario Gabelli 2014-09-30 Reduce-0.01%$41.05 - $43.69
($42.33)
$ 45.778%Reduce -38.44%98,937
ABTRay Dalio 2014-09-30 Sold Out -0.01%$41.05 - $43.69
($42.33)
$ 45.778%Sold Out0
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 45.7717%New holding, 1665688 sh.1,665,688
ABTKen Fisher 2014-06-30 Add$37.02 - $41
($39.24)
$ 45.7717%Add 106.12%18,027
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 45.7717%Reduce -23.73%932,181
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 45.7719%Add 7.9%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 45.7719%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 45.7719%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 45.7719%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 45.7724%New holding, 3250000 sh.3,250,000
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 45.7724%Add 23.45%179,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 45.7724%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 45.7724%Sold Out0
ABTRichard Pzena 2013-09-30 Add0.46%$32.93 - $36.88
($35.12)
$ 45.7730%Add 49.22%6,449,283
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 45.7730%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 45.7730%New holding, 118700 sh.118,700
ABTKen Fisher 2013-09-30 Reduce$32.93 - $36.88
($35.12)
$ 45.7730%Reduce -21.02%8,439
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 45.7730%Reduce -4.79%13,727,856
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Dodge & Cox 2014-09-3039,62800+7.4%
ABT Richard Pzena 2014-09-307,287,5230.481.7+1.25%
ABT Vanguard Health Care Fund 2014-09-307,591,4000.50.81
ABT Robert Olstein 2014-09-30182,0000.010.99
ABT Robert Bruce 2014-09-30229,3000.022.6
ABT PRIMECAP Management 2014-09-3017,089,2571.130.76-0.22%
ABT Mason Hawkins 2014-09-3012,483,5660.832.8-8.8%
ABT Jean-Marie Eveillard 2014-09-301,426,9190.090.15-14.33%
ABT George Soros 2014-09-30797,1810.050.25-14.48%
ABT Ken Fisher 2014-09-3011,26100-37.53%
ABT Mario Gabelli 2014-09-3098,9370.010.02-38.44%
ABT Ray Dalio 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Contreras JaimeSenior Vice President 2014-11-25Sell51,600$44.07-1.52view
Contreras JaimeSenior Vice President 2014-11-10Sell6,300$43.68-0.64view
WHITE MILES DChairman and CEO 2014-10-29Sell440,800$42.522.07view
Ford Robert BSenior Vice President 2014-07-01Sell0$02.07view
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.9511.42view
Landgraf John CExecutive Vice President 2014-03-03Sell17,293$39.3810.21view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.0111.25view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.0111.25view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.3710.24view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.9511.42view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Top 7 Dividend Aristocrats: The Best of The Best Dec 10 2014 
    6 Stocks Giving Investors Potential Dividend Hikes In December Dec 04 2014 
    Dividend Aristocrats In Focus Part 45: AbbVie Nov 24 2014 
    Dividend Aristocrats In Focus Part 41: Abbott Laboratories (ABT) Nov 17 2014 
    Sure Bets: Slow-Changing Industries for Long-Term Investors Oct 01 2014 
    Market Indicators That Could Spell Trouble for Investors Sep 29 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Weekly 52-Week Highs Highlight: ABT, SWK, LMT, AMGN Sep 13 2014 


    More From Other Websites
    9:07 am Abbott Labs commences tender offer and consent solicitation for CFR International SpA 5.125%... Dec 15 2014
    Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes... Dec 15 2014
    Abbott Labs raises dividend to 24 cents Dec 12 2014
    Abbott Labs raises dividend to 24 cents Dec 12 2014
    Abbott raises quarterly dividend to 24 cents a share from 22 cents Dec 12 2014
    Abbott Announces Increase in Quarterly Dividend Dec 12 2014
    Abbott Completes Acquisition of Veropharm Dec 12 2014
    Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe Dec 11 2014
    Zoetis: An attractive business model Dec 10 2014
    The Dollar and the Damage Done Dec 09 2014
    France, Germany suspend some drug approvals over Indian data Dec 06 2014
    Impact of Malnutrition in U.S. at $157 Billion Annually Dec 04 2014
    Bulls can't get enough of Abbott Labs Dec 03 2014
    Abbott Goes Beyond House of Brands, Boosts Parent Company Marketing Dec 03 2014
    Abbott Labs attracts bullish trades Dec 03 2014
    Your first trade tomorrow: CP, ABT, BBRY & F Dec 02 2014
    Unusual Activity: Abbott Labs Dec 02 2014
    Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million... Dec 01 2014
    Appointment of a Non-Executive Director Nov 19 2014
    Zoetis 2015 Guidance Misses As Buyout Theories Abound Nov 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK